Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (68)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (2)
Immunology (32)
Inflammation and immunity (53)
Microbiology (21)
Model Organisms (4)
Mouse (2)
Neuroscience (58)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
VIB
Tel.: +32 9 244 66 11
info*Replace*With*At*Sign*vib.be
Recent press releases
How tech transfer transforms new technologies into life-impacting solutions
13 December 2016
People in VIB are well aware of our adage: basic research as a starting point for tangible solutions that benefit society. But translating a paper or a technology into a groundbreaking new drug or agricultural application doesn’t happen overnight.
Core facilities moving towards smart research partnerships
9 December 2016
Science and technology are becoming increasingly intertwined. Without high-tech infrastructure, many breakthroughs in life sciences wouldn’t be possible.
Scientists show NLRP2 protein’s role in maintaining fertility later in life
6 December 2016
Mohamed Lamkanfi (VIB–UGent) demonstrated in animal models that a protein (NLRP2) plays an important role in early embryogenesis, the process of cell division in fertilized eggs that occurs before they implant into the lining of the uterus.
Ilse Gijselinck wins Dr. Karel-Lodewijk Verleysen award
3 December 2016
The Belgian Royal Academy of Medicine has granted the Dr. Karel-Lodewijk Verleysen award to Ilse Gijselinck, postdoc at the VIB Department of Molecular Genetics (University of Antwerp).
V-Bio Ventures closes first life sciences fund, raising over € 75 million
1 December 2016
V-Bio Ventures announces the final closing of its V-Bio Ventures Fund 1 ARKIV fund with € 76 million in capital commitments. This successful fundraising makes V-Bio Ventures one of the largest European first time life sciences investment funds.
ERC Consolidator Grants for three VIB scientists
30 November 2016
The European Research Council (ERC) has awarded 3 VIB scientists a consolidator grant: Stein Aerts (VIB-KU Leuven), Martin Guilliams (VIB-UGent) and Rouslan Efremov (VIB-VUB).
A change of heart: Epigenetic basis of cardiac hypertrophy uncovered
29 November 2016
Researchers uncovered the molecular control mechanisms responsible for the different biological changes seen in cardiac hypertrophy induced by pathology compared to exercise. These findings point the way for the design of new treatments for heart disease.
Technology watch: novel ways to look at the transcriptome
26 November 2016
Technologies for gene expression analysis have changed dramatically in the last few years. From Northern blotting and microarray-based gene expression profiling all the way to RNA-sequencing.
VIB scientists develop diagnostic tool for Familial Mediterranean Fever
24 November 2016
Researchers at VIB and Ghent University have developed a tool to diagnose Familial Mediterranean Fever (FMF). Particularly common among Mediterranean populations, this genetic disease is characterized by inflammation, fever and severe pain.
VIB-KU Leuven scientists discover neuron-producing stem cells in the membranes covering the brain
23 November 2016
In a cross-domain study directed by professor Peter Carmeliet (VIB – KU Leuven), researchers discovered unexpected cells in the protective membranes that enclose the brain, the so called meninges.
OSPP: Welcoming open science with open arms
19 November 2016
VIB is a founding member of EU-Life, an alliance of top European life sciences research centers. EU-Life was recently appointed by the European Commission to represent research institutions on its new Open Science Policy Platform.
Restoring flawed tumor vessels could lead to better cancer treatments
17 November 2016
Researchers at VIB and KU Leuven have found a novel way to normalize the dysfunctional blood vessels that are typical for tumors. Those vessels play a pivotal role in cancer metastasis.
Research from the group of Sarah Fendt reveals how succinate dehydrogenase is linked to both tumor and neurodegeneration
15 November 2016
Sarah-Maria Fendt (VIB-KU Leuven): “In this project we have studied mutations in the enzyme succinate dehydrogenase, which are associated with tumors, but also neurodegeneration.
Quickscan articles
12 November 2016
Quickscan scientific publications
Neat1 and SAMMSON: similar, yet different anti-cancer targets
12 November 2016
A team of researchers led by Chris Marine (VIB-KU Leuven) has shown that NEAT1, a long non-coding RNA, plays an important role in the survival of highly dividing cells – cancer cells in particular.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Next»
Page Content Zone 2
Page Content Zone 3